| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.14▼ | 1.14▼ | 1.14▼ | 1.14▼ | 1.22▼ |
| MA10 | 1.14▼ | 1.14▼ | 1.15▼ | 1.21▼ | 1.62▼ |
| MA20 | 1.14▼ | 1.15▼ | 1.16▼ | 1.22▼ | 1.89▼ |
| MA50 | 1.15▼ | 1.15▼ | 1.20▼ | 1.70▼ | 1.94▼ |
| MA100 | 1.16▼ | 1.21▼ | 1.21▼ | 1.96▼ | 3.35▼ |
| MA200 | 1.16▼ | 1.21▼ | 1.37▼ | 1.95▼ | 27.29▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.001▼ | 0.000▲ | 0.018▲ | -0.103▼ |
| RSI | 23.123▼ | 36.715▼ | 35.688▼ | 31.675▼ | 34.801▼ |
| STOCH | 0.000▼ | 22.778 | 20.635 | 24.811 | 4.026▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -85.967▼ | -98.397▼ |
| CCI | -379.915▼ | -167.587▼ | -163.624▼ | -97.638 | -107.034▼ |
| CDL | $PHIO Engulfing Candlestick Pattern Detected | Set Alert |
|
Thursday, August 14, 2025 03:16 PM
Phio Pharmaceuticals is focused on developing next-generation cancer therapies using its proprietary INTASYL technology. The INTASYL platform enables the silencing of specific genes used by cancer ...
|
|
Thursday, August 14, 2025 01:14 PM
Phio's ongoing Phase 1b dose escalation clinical trial (NCT 06014086) is designed to evaluate the safety and tolerability of neoadjuvant use of intratumoral PH-762 in Stages 1, 2 and 4 cutaneous ...
|
|
Friday, July 25, 2025 12:04 PM
King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical company developing therapeutics using its ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/12/25 | 1.16 | 1.17 | 1.12 | 1.12 | 183,973 |
| 11/12/25 | 1.17 | 1.1797 | 1.14 | 1.14 | 123,294 |
| 10/12/25 | 1.14 | 1.20 | 1.13 | 1.17 | 222,895 |
| 09/12/25 | 1.16 | 1.17 | 1.07 | 1.15 | 696,651 |
| 08/12/25 | 1.31 | 1.31 | 1.12 | 1.13 | 1,006,961 |
| 05/12/25 | 1.37 | 1.4263 | 1.31 | 1.31 | 283,111 |
| 04/12/25 | 1.29 | 1.37 | 1.255 | 1.35 | 378,418 |
| 03/12/25 | 1.22 | 1.32 | 1.19 | 1.29 | 703,176 |
| 02/12/25 | 1.24 | 1.2699 | 1.21 | 1.23 | 287,030 |
| 01/12/25 | 1.23 | 1.30 | 1.22 | 1.25 | 143,557 |
|
|
||||
|
|
||||
|
|